Coridea NC1, Inc. — Form D/A
Coridea NC1, Inc. of New York, NY, a company, filed a Form D amendment with the SEC on 2011-10-17. The offering totals $3.0M, of which $3.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2011-10-17
- Form: D/A
- Accession: 0001508105-11-000001
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $3.0M
- Amount sold: $3.0M
- Investors: 3
- Date of first sale: 2010-12-13
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-152096
Issuer
- Name: Coridea NC1, Inc.
- CIK: 0001508105
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2010
- Address: c/o G&L Consulting, LLC, New York, NY, 10001
- Phone: 212-929-6600
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Neil A Exter | Director | Boston, MA |
| Jonathan A Wyler | Director | Teaneck, NJ |
| Mitchell S Bloom | Executive Officer | New York, NY |
| Mark R Gelfand | Executive Officer | New York, NY |
| Jonathan S Wyler | Director | New York, NY |
| Neil S Exter | Director | New York, NY |
| Howard R Levin, M.D. | Director | New York, NY |
| Howard R Levin, M.D. | Executive Officer | New York, NY |
Other filings by this issuer (2)
More